Results 211 to 220 of about 311,988 (356)

Nanoparticle‐Based Tolerogenic Vaccines: Next‐Generation Strategies for Autoimmune and Allergic Disease Therapies

open access: yesAngewandte Chemie, EarlyView.
Nanoparticle‐based tolerogenic vaccines harness controlled antigen delivery and immunomodulation to establish tolerance in autoimmunity and allergy. This review outlines how nanoparticle design (size, shape, composition, administration route) influences biodistribution and immune‐cell targeting.
Benjamin E. Nachod   +3 more
wiley   +2 more sources

Digital ulcer management in patients with systemic sclerosis

open access: green, 2014
Roberta Gualtierotti   +5 more
openalex   +1 more source

Semi-Supervised Generative Models for Disease Trajectories: A Case Study on Systemic Sclerosis [PDF]

open access: green
Cécile Trottet   +13 more
openalex   +1 more source

Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment

open access: yesAnnals of Neurology, EarlyView.
Cladribine tablets are approved for relapsing multiple sclerosis, mediating their clinical effect by moderately depleting lymphocytes. In a prospective, monocentric study including 22 patients completing 2 annual cycles of cladribine, B‐ and T‐cell receptor repertoires and relapse activity were assessed at baseline and after 24 months. T‐cell clonality
Tilman Schneider‐Hohendorf   +8 more
wiley   +1 more source

Atypical lung emphysematous changes in systemic sclerosis. [PDF]

open access: yesLung India
Medeiros AK   +4 more
europepmc   +1 more source

No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis [PDF]

open access: hybrid, 2009
M. E. Hettema   +5 more
openalex   +1 more source

Progressive Systemic Sclerosis

open access: yesInternational Journal of Clinical Practice, 1964
openaire   +2 more sources

Home - About - Disclaimer - Privacy